Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 116 (CCDC116) is a protein encoded by the CCDC116 gene located on human chromosome 22q11.21. The protein is 612–613 amino acids long and contains a coiled-coil domain, but its precise molecular and cellular functions remain poorly characterized[2][5][7]. CCDC116 localizes to the centrosome, implicating a role in centrosomal architecture or function[1]. Immunohistochemical data show expression in most insulin-producing pancreatic islet cells, somatostatin cells, and pancreatic polypeptide cells, but not in glucagon or ghrelin cells, suggesting possible involvement in endocrine regulation and the biology of endocrine pancreatic tumors[7][1]. The gene has been investigated for potential associations with various cancers such as lung and prostate cancer, with genetic studies identifying variants linked to lung cancer susceptibility[1][2][5]. Proteomic and expression profiling also suggest a role in testis and potentially in ciliary biology[5]. However, there are no known drugs targeting CCDC116, and neither a therapeutic nor a validated biomarker role has been established to date[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 116 (CCDC116).